Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581] (Q24799720)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Nonparametric Estimation from Incomplete Observations

7 April 2017

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Drug Abuse: Hedonic Homeostatic Dysregulation

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Development of a Rating Scale for Primary Depressive Illness

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Evaluation of survival data and two new rank order statistics arising in its consideration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

The neurobiology of drug addiction

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Baclofen attenuates the reinforcing effects of cocaine in rats

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats

30 May 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Baclofen antagonizes intravenous self-administration of nicotine in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Baclofen decreases methamphetamine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Attenuation of morphine withdrawal signs by the GABA(B) receptor agonist baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

The effects of ventral tegmental administration of GABA(A), GABA(B), NMDA and AMPA receptor agonists on ventral pallidum self-stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

The effects of ventral tegmental administration of GABAA, GABAB and NMDA receptor agonists on medial forebrain bundle self-stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Baclofen as a cocaine anti-craving medication: a preliminary clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Rapid suppression of alcohol withdrawal syndrome by baclofen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Buprenorphine: a controlled clinical trial in the treatment of opioid dependence

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Ability of baclofen in reducing alcohol intake and withdrawal severity: I--Preclinical evidence.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

The GABAB agonist baclofen modifies cocaine self-administration in rats.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Predictors of patient retention in a newly established methadone maintenance treatment programme

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293465

Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice

28 November 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

The development of a Short Opiate Withdrawal Scale (SOWS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-244X-3-16

Increased mesolimbic GABA concentration blocks heroin self-administration in the rat

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14624703